Lorna Harries

Company: SENISCA

Job title: Chief Scientific Officer

Seminars:

Oligo-Senotherapeutics for Improving Health Span 5:00 pm

Dysregulation of RNA processing is a new and druggable hallmark of aging Identification of traction points for the attenuation of senescence phenotypes Unravelling a platform technology that can be applied for the treatment of any disease driven by senescence including eye, lungs, and jointsRead more

day: Day One